This imbalance favors the Ang II/AT1R axis of the RAS, thus triggering deleterious events including inflammation and fibrosis, and in the kidneys may be a factor implied in the observed relapse of glomerular disease after COVID-19 vaccination [66]. Here, AGTR1 is linked to glomerular disorder.